TWI740600B - Method for estimating degree of arterial occlusion - Google Patents

Method for estimating degree of arterial occlusion Download PDF

Info

Publication number
TWI740600B
TWI740600B TW109127049A TW109127049A TWI740600B TW I740600 B TWI740600 B TW I740600B TW 109127049 A TW109127049 A TW 109127049A TW 109127049 A TW109127049 A TW 109127049A TW I740600 B TWI740600 B TW I740600B
Authority
TW
Taiwan
Prior art keywords
artery
cross
vasodilation
image frames
average
Prior art date
Application number
TW109127049A
Other languages
Chinese (zh)
Other versions
TW202206017A (en
Inventor
祁甡
林柏霖
李應湘
劉俞旻
徐琅
何若菁
徐銓
黃瀚平
Original Assignee
台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院
國立陽明交通大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院, 國立陽明交通大學 filed Critical 台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院
Priority to TW109127049A priority Critical patent/TWI740600B/en
Application granted granted Critical
Publication of TWI740600B publication Critical patent/TWI740600B/en
Publication of TW202206017A publication Critical patent/TW202206017A/en

Links

Images

Abstract

Disclosed herein is a method for estimating a degree of arterial occlusion in a subject. The method comprises: (a) providing a plurality of image frames of an artery of the subject taken in sequence; (b) selecting a plurality of cross-sections of the artery based on the plurality of image frames of the step (a), and determining a maximum diameter and a minimum diameter of each of the plurality of cross-sections of the artery among the plurality of image frames; (c) calculating an average vasodilation ratio of the artery base on the maximum diameter and the minimum diameter of each the plurality of cross-sections of the artery determined in the step (b); and (d) determining the degree of arterial occlusion of the artery based on the average vasodilation ratio calculated in the step (c).

Description

用以評估動脈阻塞程度的方法Methods used to assess the degree of arterial blockage

本揭示內容是關於用以評估動脈阻塞程度的方法。特別是有關於一種可藉由一動脈的直徑差異來決定平均血管舒張比,藉以評估血管阻塞程度的方法。This disclosure is about methods used to assess the degree of arterial blockage. In particular, it relates to a method that can determine the average vasodilation ratio based on the difference in the diameter of an artery to assess the degree of vascular occlusion.

動脈狹窄是位於心臟左心室出口(主動脈開始)處的狹窄,且已經是全球性心臟衰竭的主要原因。用以評估心臟狹窄的常規方法涉及透過視覺或是藉由定量冠狀動脈血管造影(Quantitative Coronary Angiography, QCA)來評估目標血管,然而,兩種方法均無法用來評估病灶對於血流在血管中流動所造成影響的動脈功能。另一方面,一般已經公認血流儲備分數(fractional flow reserve, 以下將以FFR代稱之)是用於決定動脈(例如:冠狀動脈)閉塞/阻塞程度的可靠指標,這是因為相較於侵入性常規血管造影,FFR可更有效地識別局部缺血所造成的病灶。實務上,已證明藉由將壓力線(pressure wire)插入狹窄的血管來測量FFR,是給予醫療從業人員在規劃血管重建(revascularization)相關決策之指引的較好選擇。Arterial stenosis is a stenosis at the exit of the left ventricle of the heart (start of the aorta), and has been the main cause of heart failure worldwide. Conventional methods for assessing heart stenosis involve visual or quantitative coronary angiography (Quantitative Coronary Angiography, QCA) to assess the target blood vessel, however, neither method can be used to assess the blood flow of the lesion in the blood vessel. The affected arterial function. On the other hand, it is generally accepted that fractional flow reserve (FFR) is a reliable indicator for determining the degree of occlusion/blockage of arteries (for example, coronary arteries). This is because it is more invasive than invasive. Conventional angiography, FFR can more effectively identify the lesions caused by ischemia. In practice, it has been proven that measuring FFR by inserting a pressure wire into a narrow blood vessel is a better choice for medical practitioners to guide decisions related to revascularization.

然而,基於壓力線的FFR測量涉及將壓力線插入血管所需之干預的相關風險,而且,對於非常窄小的血管狹窄,壓力線可能會引起額外的壓降(pressure drop)。因此,已有一些機械模型被提出來降低侵入性過程導致的風險,該些機械模型是使用數學方程式來模擬從醫學影像擷取的病患冠狀血管的三維解剖模型中的血流物理學。這樣的方法則依賴物理基礎的數學方程式來模擬靜止與充血時的生理狀態,藉以允許相關人士可在電腦上求解方程式並數字化地決定個體病患的血流量與壓降。However, pressure line-based FFR measurement involves risks associated with the intervention required to insert the pressure line into a blood vessel, and for very narrow blood vessel stenosis, the pressure line may cause an additional pressure drop. Therefore, some mechanical models have been proposed to reduce the risk caused by invasive processes. These mechanical models use mathematical equations to simulate the blood flow physics in the three-dimensional anatomical model of the patient's coronary blood vessels extracted from medical images. Such a method relies on physical-based mathematical equations to simulate the physiological state of rest and hyperemia, thereby allowing relevant persons to solve the equations on a computer and digitally determine the blood flow and pressure drop of individual patients.

然而,這類機械模型基於物理方程式之模型前置作業與數值解,連帶具有高運算成本與高運算複雜性等缺點。此外,這樣的機械模型通常僅包含解剖以及部分生理測量卻忽略其他有意義的數值。即便機器學習可以應用在一或多種血流動力學指數的計算上,仍存在有大量的運算成本,因此不適於分秒必爭的臨床診斷。However, this type of mechanical model is based on the model pre-work and numerical solution of physical equations, and has the disadvantages of high computational cost and high computational complexity. In addition, such mechanical models usually only contain anatomical and some physiological measurements but ignore other meaningful values. Even if machine learning can be applied to the calculation of one or more hemodynamic indexes, there are still a lot of calculation costs, so it is not suitable for clinical diagnosis where every second counts.

有鑑於此,相關領域亟需一種用以對一個體評估動脈阻塞程度的改良方法。In view of this, the related field urgently needs an improved method for evaluating the degree of arterial blockage in an individual.

為了給讀者提供基本的理解,以下提供本揭示內容的簡要發明內容。此發明內容不是本揭示內容的廣泛概述,同時非用來識別本發明的關鍵/必需元件或勾勒本發明的範圍。其唯一目的是以簡化的概念形式呈現本揭示內容的一些概念,以作為呈現於後文中更詳細描述的序言。In order to provide readers with a basic understanding, the following provides a brief summary of the present disclosure. This summary of the invention is not an extensive overview of the disclosure, and is not used to identify the key/essential elements of the invention or outline the scope of the invention. Its sole purpose is to present some concepts of this disclosure in a simplified conceptual form as a prelude to the more detailed description presented later.

如本文實施及廣泛描述的,本揭示內容旨在提供一種主要藉由非侵入操作並基於血管的直徑差異,得以評估一個體動脈之阻塞程度的方法,特別是具體提供特徵在於不包含直接測量血管內血流之步驟的評估方法。As implemented and broadly described herein, the present disclosure aims to provide a method for assessing the degree of obstruction of a body artery mainly through non-invasive operations and based on the difference in blood vessel diameters. In particular, it specifically provides features that do not include direct measurement of blood vessels. Evaluation method of internal blood flow steps.

在本揭示內容一態樣中,是關於一種用以評估一個體之一動脈阻塞程度的方法。該方法包含:一種用以評估一個體之一動脈阻塞程度的方法,包含:(a)連續拍攝該動脈,以得到該動脈的複數個影像幀;(b)基於步驟(a)得到的該複數個影像幀,選定該動脈的複數個截面,並決定該動脈於該複數個影像幀當中,各該複數個截面的一最大直徑及一最小直徑;(c)根據步驟(b)之各該複數個截面的該最大直徑及該最小直徑,計算該動脈的一平均血管舒張比;以及(d)根據步驟(c)之該平均血管舒張比,判斷該動脈的阻塞程度。In one aspect of the present disclosure, it relates to a method for assessing the degree of clogged arteries in a body. The method includes: a method for assessing the degree of obstruction of an artery in a body, including: (a) continuously photographing the artery to obtain a plurality of image frames of the artery; (b) based on the plurality of images obtained in step (a) Select multiple cross sections of the artery, and determine a maximum diameter and a minimum diameter of each of the multiple cross sections of the artery in the multiple image frames; (c) according to each of the plurality of steps (b) Calculating an average vasodilation ratio of the artery for the maximum diameter and the minimum diameter of each cross section; and (d) judging the degree of blockage of the artery according to the average vasodilation ratio of step (c).

根據本揭示內容之實施方式,前述方法的特徵在於不包含量測該個體之動脈血流的步驟;前述方法又另一特徵在於非侵入性地操作,且不使用導管、護套、導引線或其組合的任一種。According to the embodiments of the present disclosure, the aforementioned method is characterized in that it does not include the step of measuring the arterial blood flow of the individual; the aforementioned method is also characterized in that it is operated non-invasively and does not use catheters, sheaths, or guide wires. Or any combination thereof.

根據本揭示內容之某些實施方式,步驟(b)是以下列步驟決定該最大直徑及該最小直徑:(i)將各該複數個影像幀彼此對齊,以決定該動脈的一邊界以及一中心軸線;(ii)根據步驟(i)之該中心軸線的法向量,選定該動脈的該複數個截面;以及(iii)基於步驟(i)的該邊界,在該複數個影像幀當中,決定步驟(ii)選定之各該複數個截面的該最大直徑及該最小直徑。According to some embodiments of the present disclosure, step (b) is to determine the maximum diameter and the minimum diameter in the following steps: (i) aligning the plurality of image frames with each other to determine a boundary and a center of the artery Axis; (ii) according to the normal vector of the central axis of step (i), select the plurality of cross-sections of the artery; and (iii) based on the boundary of step (i), among the plurality of image frames, determine the step (ii) The maximum diameter and the minimum diameter of each of the plurality of cross-sections selected.

較佳地,在步驟(i)中,是藉由在對齊的該複數個影像幀上執行多項式回歸,以決定該動脈的該中心軸線。Preferably, in step (i), the central axis of the artery is determined by performing polynomial regression on the aligned plural image frames.

根據本揭示內容的實施方式,在步驟(c)中,是藉由以下方程式(1)及(2),以計算該平均血管舒張比:

Figure 02_image001
(1),
Figure 02_image003
(2), 其中, i是該動脈之該複數個截面的任一截面; n是該複數個截面的總數; D max,i 是在該截面 i上,該動脈的該最大直徑; D min,i 是在該截面 i上,該動脈的該最小直徑; V i 是對應該截面 i的一血管舒張比;且 V avg 表示該動脈的該平均血管舒張比。 According to the embodiment of the present disclosure, in step (c), the average vasodilation ratio is calculated by the following equations (1) and (2):
Figure 02_image001
(1),
Figure 02_image003
(2), where i is any cross section of the plurality of cross sections of the artery; n is the total number of the plurality of cross sections; D max,i is the maximum diameter of the artery on the cross section i ; D min, i is the smallest diameter of the artery on the section i ; V i is a vasodilation ratio corresponding to the section i ; and Vavg represents the average vasodilation ratio of the artery.

在某些實施方式中,在步驟(a)中,該複數個影像幀是以約每秒30幀至60幀的一幀頻(frame rate)所攝得。In some embodiments, in step (a), the plurality of image frames are captured at a frame rate of about 30 to 60 frames per second.

在某些實施方式中,在步驟(a)中,該複數個影像幀是在約5秒至8秒的一期間所攝得。In some embodiments, in step (a), the plurality of image frames are captured in a period of about 5 seconds to 8 seconds.

透過前述步驟,本揭示內容的方法可準確快速地評估個體動脈的阻塞程度。Through the foregoing steps, the method of the present disclosure can accurately and quickly assess the degree of clogging of individual arteries.

在參閱下文實施方式後,本發明所屬技術領域中具有通常知識者當可輕易瞭解本發明之基本精神及其他發明目的,以及本發明所採用之技術手段與實施態樣。After referring to the following embodiments, those skilled in the art to which the present invention pertains can easily understand the basic spirit and other objectives of the present invention, as well as the technical means and implementation aspects of the present invention.

為了使本揭示內容的敘述更加詳盡與完備,下文針對了本發明的實施態樣與具體實施例提出了說明性的描述;但這並非實施或運用本發明具體實施例的唯一形式。實施方式中涵蓋了多個具體實施例的特徵以及用以建構與操作這些具體實施例的方法步驟與其順序。然而,亦可利用其他具體實施例來達成相同或均等的功能與步驟順序。In order to make the description of the present disclosure more detailed and complete, the following provides an illustrative description for the implementation aspects and specific embodiments of the present invention; this is not the only way to implement or use the specific embodiments of the present invention. The implementation manners cover the characteristics of a number of specific embodiments and the method steps and sequences used to construct and operate these specific embodiments. However, other specific embodiments can also be used to achieve the same or equal functions and sequence of steps.

I.  定義I. Definition

為了便於說明,此處統整性地說明本說明書、實施例以及後附的申請專利範圍中所記載的特定術語。除非本說明書另有定義,此處所用的科學與技術詞彙之含義與本發明所屬技術領域中具有通常知識者所理解與慣用的意義相同。此外,在不和上下文衝突的情形下,本說明書所用的單數名詞涵蓋該名詞的複數型;而所用的複數名詞時亦涵蓋該名詞的單數型。具體而言,除非上下文另有明確說明,本文和後附的申請專利範圍所使用的單數形式「一」(a及an)包含複數形式。此外,在本說明書與申請專利範圍中,「至少一」(at least one)與「一或更多」(one or more)等表述方式的意義相同,兩者都代表包含了一、二、三或更多。For ease of description, the specific terms described in the specification, the embodiments and the appended patent scope are collectively described here. Unless otherwise defined in this specification, the scientific and technical terms used herein have the same meaning as understood and used by those with ordinary knowledge in the technical field of the present invention. In addition, without conflict with the context, the singular nouns used in this specification cover the plural nouns; and the plural nouns used also cover the singular nouns. Specifically, unless the context clearly indicates otherwise, the singular form "one" (a and an) used in the scope of the patent application herein and appended includes plural forms. In addition, in this specification and the scope of the patent application, expressions such as "at least one" and "one or more" have the same meaning, and both of them mean that they include one, two, and three. Or more.

雖然用以界定本發明較廣範圍的數值範圍與參數皆是約略的數值,此處已盡可能精確地呈現具體實施例中的相關數值。然而,任何數值本質上不可避免地含有因個別測試方法所致的標準偏差。在此處,「約」(about)通常係指實際數值在一特定數值或範圍的正負10%、5%、1%或0.5%之內。或者是,「約」一詞代表實際數值落在平均值的可接受標準誤差之內,視本發明所屬技術領域中具有通常知識者的考量而定。除了實驗例之外,或除非另有明確的說明,當可理解此處所用的所有範圍、數量、數值與百分比(例如用以描述材料用量、時間長短、溫度、操作條件、數量比例及其他相似者)均經過「約」的修飾。因此,除非有相反的說明,本說明書與附隨申請專利範圍所揭示的數值參數皆為約略的數值,且可視需求而更動。至少應將這些數值參數理解為所指出的有效位數與套用一般進位法所得到的數值。Although the numerical ranges and parameters used to define the broader scope of the present invention are approximate numerical values, the relevant numerical values in the specific embodiments are presented here as accurately as possible. However, any value inevitably contains standard deviations due to individual test methods. Here, "about" usually means that the actual value is within plus or minus 10%, 5%, 1%, or 0.5% of a specific value or range. Or, the word "about" means that the actual value falls within the acceptable standard error of the average value, depending on the consideration of a person with ordinary knowledge in the technical field of the present invention. In addition to the experimental examples, or unless otherwise clearly stated, all ranges, quantities, values and percentages used herein (for example, used to describe the amount of material, length of time, temperature, operating conditions, quantity ratios and other similar Those) have been modified by "about". Therefore, unless otherwise stated, the numerical parameters disclosed in this specification and the accompanying patent scope are approximate values and can be changed according to requirements. At least these numerical parameters should be understood as the indicated effective number of digits and the value obtained by applying the general carry method.

「影像幀」(image frame(s)或frame(s))一詞是指藉由照片擷取裝置及/或軟體拍攝的一或多個靜止影像,其可組成一個完整的移動畫面。一般而言,可將多個單一圖像紀錄在攝影膠片條上或作為具有間順序的數位檔案,且這些多個單一圖像可以集合呈現一個連續移動動作。可以任何醫學影像裝置(例如X射線造影、磁振成像、醫學超音波掃描、內視鏡檢、彈性影像(elastography)、觸覺影像、熱成像、正電子發射斷層攝影術(positron emission tomography, PET)以及單光子發射電腦斷層掃描攝影術(single-photon emission computed tomography)來擷取本揭示內容的影像幀。「連續影像幀」、「依序的影像幀」或「影像幀序列」一詞是在一段給定時間內拍攝的連續圖像,且拍攝每一幀的頻率稱為「幀頻」或是「框率」(frame rate或frame frequency),通常以赫茲(hertz)表示。The term "image frame(s)" (image frame(s) or frame(s)) refers to one or more still images captured by a photo capture device and/or software, which can form a complete moving picture. Generally speaking, multiple single images can be recorded on a photo film strip or as a digital file with inter-sequence, and these multiple single images can be aggregated to present a continuous movement. Any medical imaging device (such as X-ray imaging, magnetic resonance imaging, medical ultrasound scanning, endoscopy, elastography, tactile imaging, thermal imaging, positron emission tomography, PET) And single-photon emission computed tomography (single-photon emission computed tomography) to capture the image frames of the present disclosure. The term "sequential image frame", "sequential image frame" or "sequence of image frames" is used in A continuous image taken within a given period of time, and the frequency at which each frame is taken is called "frame rate" or "frame rate" (frame rate or frame frequency), usually expressed in hertz.

「血管舒張」(vasodilation)一詞是指由血管壁內的平滑肌肉細胞之舒張所造成的血管變寬的現象,所謂的血管壁通常是指動脈的血管,例如主動脈、冠狀動脈以及大動脈。「血管舒張比」(vasodilation ratio)用來表示通常收到血管閉塞或阻塞影響的血管加寬的程度。在本揭示內容中,「血管舒張比」(vasodilation ratio)是透過在一段血管中一給定橫切面或截面的最大直徑與最小直徑之間的差值來決定的,而非透過測量該血管中的血流量來決定。The term "vasodilation" refers to the widening of blood vessels caused by the relaxation of smooth muscle cells in the vascular wall. The so-called vascular wall usually refers to the blood vessels of the arteries, such as the aorta, coronary arteries and aorta. "Vasodilation ratio" (vasodilation ratio) is used to express the degree of widening of blood vessels that are usually affected by vascular occlusion or obstruction. In the present disclosure, the "vasodilation ratio" is determined by the difference between the maximum diameter and the minimum diameter of a given cross-section or cross-section in a section of blood vessel, not by measuring the blood vessel To determine the blood flow.

「影像對位」(image registration) 或「影像對齊」 (image alignment)一詞是指將影像中不同資料組或資訊組(例如:多張照片/影像、視野或時間)轉換至一個共同座標系統的過程。在本揭示內容中,「影像對位」或「影像對齊」是應用在多張醫學影像。具體來說,用來執行「影像對位」或「影像對齊」之演算法的具體概念是分別指定其中一影像為目標影像(target image),其餘則指定為來源影像(source image)或移動影像(moving image),且「影像對位」或「影像對齊」涉及空間性地轉形來源影像或移動影像以與目標影像對齊。The term "image registration" or "image alignment" refers to the conversion of different data groups or information groups in an image (for example, multiple photos/images, field of view, or time) into a common coordinate system the process of. In the present disclosure, "image alignment" or "image alignment" is applied to multiple medical images. Specifically, the specific concept of the algorithm used to perform "image alignment" or "image alignment" is to designate one of the images as the target image, and the others as the source image or moving image. (moving image), and "image alignment" or "image alignment" involves spatially transforming the source image or moving the image to align with the target image.

在本文中,「個體」(subject)是指能夠施以本揭示內容方法的哺乳類動物(包含人類)。除非另有指明,「個體」一般包含雄性與雌性。In this article, "subject" refers to mammals (including humans) capable of applying the method of the present disclosure. Unless otherwise specified, "individuals" generally include males and females.

II.  具體實施方式II. Specific implementation

本揭示內容是關於一種基於計算一給定血管的直徑差異來評估一個體血管阻塞程度的方法。The present disclosure relates to a method for evaluating the degree of obstruction of a blood vessel in a body based on calculating the difference in diameter of a given blood vessel.

據此,本揭示內容的態樣是關於用以評估一個體之動脈阻塞程度的方法。請參考第1圖,其繪示本揭示內容方法100步驟的流程圖。本揭示內容方法100至少包含下列步驟,該些步驟在第1圖分別以符號102至108表示: (a) 連續拍攝該動脈,以得到該動脈的複數個影像幀; (b) 基於步驟(a)得到的該複數個影像幀,選定該動脈的複數個截面,並決定該動脈於該複數個影像幀當中,各該複數個截面的一最大直徑及一最小直徑; (c) 根據步驟(b)之各該複數個截面的該最大直徑及該最小直徑,計算該動脈的一平均血管舒張比;以及 (d) 根據步驟(c)之該平均血管舒張比,判斷該動脈的阻塞程度。 Accordingly, the aspect of the present disclosure relates to a method for assessing the degree of arterial blockage in a body. Please refer to FIG. 1, which shows a flowchart of the steps of the method 100 of the present disclosure. The method 100 of the present disclosure includes at least the following steps, which are denoted by symbols 102 to 108 in FIG. 1 respectively: (a) Continuously photograph the artery to obtain multiple image frames of the artery; (b) Based on the plurality of image frames obtained in step (a), select a plurality of cross sections of the artery, and determine a maximum diameter and a minimum diameter of each of the plurality of cross sections of the artery in the plurality of image frames; (c) calculating an average vasodilation ratio of the artery according to the maximum diameter and the minimum diameter of each of the plurality of cross-sections in step (b); and (d) Judging the degree of blockage of the artery according to the average vasodilation ratio of step (c).

在進行本揭示內容的方法100之前,首先先選定一人類動脈的一區段(通常是阻塞較為嚴重的區段)來進行影像拍攝。在某些實施方式中,較佳是選擇冠狀動脈的左前降支(left anterior descending branch)。接著執行X射線造影以擷取所述動脈的選定區段的影像,其中在X射線造影之前已先行對該動脈注入X射線顯影劑。X射線顯影劑種類的選擇及注射劑量可依據各個體所需而變化,只要本領域具有通常知識者能夠判讀所產生的影像即可。Before proceeding to the method 100 of the present disclosure, first select a section of a human artery (usually a section with more severe blockage) for imaging. In some embodiments, it is preferable to select the left anterior descending branch of the coronary artery. Then, X-ray contrast is performed to capture images of the selected section of the artery, wherein the X-ray contrast agent has been injected into the artery before the X-ray contrast. The choice of the type of X-ray developer and the injection dose can vary according to the needs of each individual, as long as a person with ordinary knowledge in the field can interpret the generated image.

替代性或是非必要性,亦可在拍攝醫學影像之前給予該個體一血管造影劑,藉以暫時性地清除選定血管內的阻塞,並立即性增加該血管內的血流。常用的血管造影劑包含,但不限於:腺苷(adenosine)、二吡待摩(dipyridamole)、硝酸異山梨酯(isosorbide dinitrate)及其組合。Alternatively or not, an angiographic contrast agent can also be given to the individual before the medical image is taken, so as to temporarily clear the blockage in the selected blood vessel and immediately increase the blood flow in the blood vessel. Commonly used angiography agents include, but are not limited to: adenosine, dipyridamole, isosorbide dinitrate, and combinations thereof.

在步驟(a),在一段時間內對該動脈的一給定區段連續拍攝其醫學影像。在一實施方式中,是在約5至8秒的期間內連續以約每秒30至60幀(例如每秒30、32、35、37、40、42、45、47、50、52、55、56、57、58、59或60幀)的頻率拍攝一特定血管區段的X射線影像。在較佳實施方式中,是在六秒之內以45赫茲(Hz)的幀頻拍攝複數個影像幀。In step (a), medical images of a given section of the artery are taken continuously for a period of time. In one embodiment, it is continuously performed at about 30 to 60 frames per second (for example, 30, 32, 35, 37, 40, 42, 45, 47, 50, 52, 55 , 56, 57, 58, 59 or 60 frames) to take X-ray images of a specific blood vessel segment. In a preferred embodiment, multiple image frames are captured at a frame rate of 45 Hertz (Hz) within six seconds.

接著,在步驟(b),在步驟(a)得到的該複數個影像幀當中,決定該動脈於一特定截面的一最大直徑及一最小直徑。較佳地,可在步驟(a)得到的該複數個影像幀當中選定該動脈的複數個截面,接著可決定該動脈在各截面的最大直徑及最小直徑。具體來說,在步驟(b)是對步驟(a)取得的複數個影像幀執行影像對位,亦即,將各該複數個影像幀彼此對齊,並接受幀分析來決定各影像幀中動脈的邊界及其中心軸線。具體而言,可透過執行常規的演算法來進行幀排列校準,例如透過特徵值演算法來決定要被判讀的動脈區段的區域與範圍。在以實施例中,是執行盧卡斯-卡納德(Kanade-Lucas-Tomasi,以下簡稱KLT)演算法,透過該演算法來固定經對齊校準的影像,接著執行追蹤演算法(Tracking algorithm)以追蹤各幀圖像上的多個特徵點並縮放及/或旋轉該幀圖像,藉此複數個影像幀的每一幀都可根據共同的特徵點彼此疊合。在某些情況下,影像幀序列的最後一幅影像幀可作為具有固定相對位置的目標影像,藉此可加速其餘影像幀的對位及校準。在對位及疊合所有影像幀之後,接著對複數個影像幀執行二值化(binarization)處理,以簡化目標物體及最小化背景資訊,藉以決定動脈血管的邊界。接著執行多項式回歸分析,以基於定出的邊界來決定中心軸線。Next, in step (b), among the plurality of image frames obtained in step (a), a maximum diameter and a minimum diameter of the artery in a specific section are determined. Preferably, a plurality of cross sections of the artery can be selected among the plurality of image frames obtained in step (a), and then the maximum diameter and minimum diameter of the artery in each cross section can be determined. Specifically, in step (b), image alignment is performed on the plurality of image frames obtained in step (a), that is, the plurality of image frames are aligned with each other, and the frames are analyzed to determine the arteries in each image frame The boundary and its central axis. Specifically, the frame arrangement calibration can be performed by executing a conventional algorithm, for example, by using a feature value algorithm to determine the area and range of the arterial segment to be interpreted. In this embodiment, the Kanade-Lucas-Tomasi (KLT) algorithm is executed, and the aligned and calibrated images are fixed by the algorithm, and then the tracking algorithm is executed. To track multiple feature points on each frame image and zoom and/or rotate the frame image, so that each frame of a plurality of image frames can be superimposed on each other according to a common feature point. In some cases, the last image frame of the image frame sequence can be used as a target image with a fixed relative position, thereby speeding up the alignment and calibration of the remaining image frames. After aligning and superimposing all image frames, binarization is performed on a plurality of image frames to simplify the target object and minimize background information, thereby determining the boundaries of arteries and blood vessels. Then perform polynomial regression analysis to determine the central axis based on the determined boundary.

同樣為步驟(b),一旦確定圖片中選定動脈的邊界及中心軸線,即可據以確定動脈的直徑。具體的作法是先在中心軸線上指定至少一取樣點。據此,在圖像中,透過該中心軸線的各取樣點的法向量,可取得選定動脈區段內的至少一截面。換句話說,藉由任一取樣點的法向量,可得到穿過該取樣點並與動脈垂直的截面。具體而言,中心軸線上的每一個取樣點均可對應形成動脈的一截面。取得截面之後,便可根據動脈兩邊界相應地求得每一影像幀的相同截面上的動脈直徑。應當理解的是取樣點或是截面的數目可根據實際需求加以變化。在本發明具體實施例中,在對位對齊影像幀中挑選複數個取樣點,例如,取樣點的數目較佳為20至500個,例如為20、30、40、50、100、200、300、400或500個。在部分實施例中,取樣點更佳為200個。由於脈搏與血流,動脈的任意選定截面的直徑會隨著時間變化,且該時間期間內連續拍攝的複數個影像幀會反映出這樣的變化。因此,對每一個取樣點來說,可經由將所收集的複數個影像幀進行排序,來決定一取樣點的最大直徑與最小直徑。The same is the step (b). Once the boundary and central axis of the selected artery in the picture are determined, the diameter of the artery can be determined. The specific method is to first specify at least one sampling point on the central axis. According to this, in the image, through the normal vector of each sampling point of the central axis, at least one cross section in the selected artery segment can be obtained. In other words, by using the normal vector of any sampling point, a cross section passing through the sampling point and perpendicular to the artery can be obtained. Specifically, each sampling point on the central axis can correspond to a cross-section of the artery. After the cross-section is obtained, the diameter of the artery on the same cross-section of each image frame can be obtained according to the two boundaries of the artery. It should be understood that the number of sampling points or sections can be changed according to actual needs. In the specific embodiment of the present invention, a plurality of sampling points are selected in the alignment image frame. For example, the number of sampling points is preferably 20 to 500, such as 20, 30, 40, 50, 100, 200, 300 , 400 or 500. In some embodiments, the sampling points are more preferably 200. Due to pulse and blood flow, the diameter of any selected cross-section of the artery will change over time, and a plurality of image frames continuously taken during this time period will reflect such changes. Therefore, for each sampling point, the maximum diameter and minimum diameter of a sampling point can be determined by sorting the collected image frames.

接著在步驟(c),基於步驟(b)所決定的最大直徑與最小直徑,可計算出該動脈的平均血管舒張比。較佳是藉由以下方程式(1)及(2)來計算平均血管舒張比:

Figure 02_image005
(1),
Figure 02_image003
(2)。 Then in step (c), based on the maximum diameter and minimum diameter determined in step (b), the average vasodilation ratio of the artery can be calculated. Preferably, the average vasodilation ratio is calculated by the following equations (1) and (2):
Figure 02_image005
(1),
Figure 02_image003
(2).

在方程式(1)及(2), i表示該動脈之該複數個截面的任一截面, n則表示該複數個截面的總數(也就是對應的取樣點的總數), D max,i 是在該截面i上,該動脈的該最大直徑, D min,i 是在該截面i上,該動脈的該最小直徑, V i 是對應該截面i的一血管舒張比,而 V avg 表示該動脈的該平均血管舒張比。 In equations (1) and (2), i represents any section of the plurality of sections of the artery, n represents the total number of the plurality of sections (that is, the total number of corresponding sampling points), and D max,i is in On the section i, the maximum diameter of the artery, D min,i is the minimum diameter of the artery on the section i, V i is a vasodilation ratio corresponding to the section i, and Vavg represents the artery’s The average vasodilation ratio.

在某些實施方式中, V avg 與一血流動力參數呈現負相關。血流動力參數可做為血流量的指標,例如冠狀血管血流儲備分數(coronary flow reserve, CFR)以及血流儲備分數(以下以FFR代稱)。在某些實施方式中,血流動力參數是FFR,其定義為狹窄血管中最大血流量與正常血管中最大血流量的比例,並可作為狹窄嚴重程度的指標。在較佳實施例中,本揭示內容的平均血管舒張比與FFR之間具有負相關,較佳地,本揭示內容的平均血管舒張比與FFR之間的相關係數為約-0.9至-0.95。在較佳實施例中,平均血管舒張比與FFR滿足以下方程式(3):

Figure 02_image007
(3)。 In some embodiments, Vavg exhibits a negative correlation with a hemodynamic parameter. Hemodynamic parameters can be used as indicators of blood flow, such as coronary flow reserve (CFR) and blood flow reserve (hereinafter referred to as FFR). In some embodiments, the hemodynamic parameter is FFR, which is defined as the ratio of the maximum blood flow in a stenotic vessel to the maximum blood flow in a normal vessel, and can be used as an indicator of the severity of the stenosis. In a preferred embodiment, the average vasodilation ratio of the present disclosure has a negative correlation with FFR. Preferably, the correlation coefficient between the average vasodilation ratio and FFR of the present disclosure is about -0.9 to -0.95. In a preferred embodiment, the average vasodilation ratio and FFR satisfy the following equation (3):
Figure 02_image007
(3).

根據本揭示內容,由於FFR是熟知的血管阻塞的指標,與FFR具有相關性的平均血管舒張比自然也可做為血管阻塞的指標。因此,在具體實施例中,根據所述方程式(3),可藉由計算反映血管阻塞程度的平均血管舒張比來獲得血管阻塞程度。According to the present disclosure, since FFR is a well-known indicator of vascular occlusion, the average vasodilation ratio correlated with FFR can naturally also be used as an indicator of vascular occlusion. Therefore, in a specific embodiment, according to the equation (3), the degree of vascular occlusion can be obtained by calculating the average vasodilation ratio reflecting the degree of vascular occlusion.

應當被理解的是,在本揭示內容方法100中,估算血管阻塞程度的步驟不涉及直接測量動脈內血流流量的步驟。更具體來說,本揭示內容僅利用血管直徑的差異作為決定動脈阻塞程度的指標。透過在一有限的時間期間內決定血管直徑的變化,接著可對該個體或病患給出合適的後續處理。It should be understood that in the method 100 of the present disclosure, the step of estimating the degree of vascular occlusion does not involve the step of directly measuring the blood flow in the artery. More specifically, the present disclosure only uses the difference in blood vessel diameter as an index to determine the degree of arterial blockage. By determining the change of blood vessel diameter within a limited period of time, appropriate follow-up treatments can then be given to the individual or patient.

此外,在本揭示內容用來估計血管阻塞程度的步驟(a)–(c)中,是以非侵入性的方式來操作的,具體來說是不使用常規上利於偵測的導管、護套、導引線或其組合的任一種。In addition, the steps (a)-(c) used to estimate the degree of vascular obstruction in the present disclosure are performed in a non-invasive manner, specifically, catheters and sheaths that are conventionally useful for detection are not used. , Guide wire or any combination thereof.

接著在步驟(d),可根據步驟(a)–(c)求得的平均血管舒張比,來判斷該目標動脈的阻塞程度。根據本揭示內容一實施方式,當平均血管舒張比的數值越大,血管阻塞程度越大;相反地,當平均血管舒張比的數值越小,則血管阻塞程度越小。在較佳實施方式中,本揭示內容以平均血管舒張比為0.2當作一個參考閾值,平均血管舒張比大於0.2,則具有較嚴重的動脈阻塞程度。Then in step (d), the degree of blockage of the target artery can be judged according to the average vasodilation ratio obtained in steps (a)-(c). According to an embodiment of the present disclosure, when the value of the average vasodilation ratio is larger, the degree of vascular occlusion is greater; conversely, when the value of the average vasodilation ratio is smaller, the degree of vascular occlusion is smaller. In a preferred embodiment, the present disclosure uses an average vasodilation ratio of 0.2 as a reference threshold. If the average vasodilation ratio is greater than 0.2, the arterial occlusion is more severe.

在非必要實施方式中,也可根據參考閾值對該個體進行後續處理。前述的後續處理可包含各種臨床上或醫學上為相關領域的技術人員所熟知的處理,也可包含個體對自身生理需求而採用的行為與處置。具體來說,可經綜合判斷個體的其餘生理狀況後,對該個體投予可改善動脈阻塞的藥物或是醫學輔助材料。舉例來說,藥物可包含血管舒張藥劑(vasodilator),像是硝酸甘油(nitroglycerin)、前列地爾 (alprostadil)、利奧西哌(riociguat)、聯胺肼(hydralazine), 米諾地爾(minoxidil)、奈西立肽(nesiritide)及硝普鹽(nitroprusside)等。醫學輔助材料則包含可增加動脈血流的血管支架(stent),甚或是針對動脈阻塞更為嚴重的情況來進行的冠狀動脈繞道手術等。In non-essential implementations, the individual may also be subjected to subsequent processing according to the reference threshold. The aforementioned subsequent treatment may include various clinically or medically well-known treatments to those skilled in the relevant field, and may also include behaviors and treatments that the individual adopts in response to his own physiological needs. Specifically, after comprehensively judging the individual's remaining physiological conditions, drugs or medical auxiliary materials that can improve arterial obstruction can be administered to the individual. For example, the drug may include vasodilators, such as nitroglycerin, alprostadil, riociguat, hydralazine, and minoxidil. ), nesiritide and nitroprusside, etc. Medical auxiliary materials include stents that can increase arterial blood flow, or even coronary artery bypass surgery for more severe arterial blockages.

下文提出多個實施例來說明本發明的某些態樣,以利本發明所屬技術領域中具有通常知識者實作本發明。不應將這些實驗例視為對本發明範圍的限制。無須進一步說明,據信所屬技術領域中具有通常知識者可根據本文的描述,最大限度地利用本發明。本文引用的所有公開文獻均透過引用其整體併入本文。A number of embodiments are presented below to illustrate certain aspects of the present invention, so as to facilitate those skilled in the art to which the present invention belongs to implement the present invention. These experimental examples should not be regarded as limiting the scope of the present invention. Without further explanation, it is believed that those with ordinary knowledge in the technical field can use the present invention to the fullest extent based on the description herein. All publications cited herein are incorporated herein by reference in their entirety.

實施例Example

1. 建立平均血管舒張比模型1. Establish an average vasodilation ratio model

從馬偕紀念醫院(臺灣)的醫療資料庫中隨機挑選經確診具有動脈狹窄的25位個體,且該資料庫中存有該些個體的臨床測量FFR值。25 individuals who were diagnosed with arterial stenosis were randomly selected from the medical database of Mackay Memorial Hospital (Taiwan), and the clinically measured FFR values of these individuals are stored in the database.

選定每一個體的左前降支動脈的一區段,並於該血管中注射1 mg 毫克的硝酸異山梨酯(isosorbide dinitrate),隨後立即在8秒的期間內拍攝連續的X射線醫學影像。幀頻為45赫茲(也就是每秒有45個影像幀),且最後一個影像幀被指定為標準模板幀。選定圖像上感興趣區域後(region of interest,ROI),以盧卡斯-卡納德方法(Kanade-Lucas-Tomasi,KLT)處理、追蹤演算法以及影像處理程序(例如縮放及選轉影像幀)來處理每一個影像幀,以使所有影像幀的共同特徵點固定於定點,且所有影像幀均透過該固定的特徵點彼此對位。接著對對位後的影像幀進行二值化處理以及多項式回歸分析,透過前述分析以確定該動脈的邊界及其中心軸線。A section of the left anterior descending artery of each individual was selected, and 1 mg of isosorbide dinitrate was injected into the blood vessel, and then continuous X-ray medical images were taken immediately after 8 seconds. The frame rate is 45 Hz (that is, there are 45 image frames per second), and the last image frame is designated as the standard template frame. After the region of interest (ROI) is selected on the image, it is processed by the Kanade-Lucas-Tomasi (KLT) method, tracking algorithm and image processing procedures (such as zooming and selecting the image) Frame) to process each image frame so that the common feature point of all image frames is fixed at a fixed point, and all image frames are aligned with each other through the fixed feature point. Then binarization processing and polynomial regression analysis are performed on the aligned image frames, and the boundary of the artery and its central axis are determined through the aforementioned analysis.

沿著動脈血管的中心軸線,取其上200個取樣點,並根據每一個取樣點的法向量可計算出對應該取樣點的直徑。Along the central axis of the arterial vessel, take 200 sampling points on it, and calculate the diameter of the corresponding sampling point according to the normal vector of each sampling point.

透過以下方程式求得每一個體的平均血管舒張比:

Figure 02_image005
(1),
Figure 02_image003
(2), 其中 i是表示動脈200個截面的任一截面; n表示複數個截面的總數(也就是對應的取樣點的總數200); D max,i 是在該截面 i上,該動脈的該最大直徑; D min,i 是在該截面 i上,該動脈的該最小直徑; V i 是對應該截面i的一血管舒張比;且 V avg 表示該動脈的該平均血管舒張比。 The average vasodilation ratio of each individual is obtained by the following equation:
Figure 02_image005
(1),
Figure 02_image003
(2), where i represents any of the 200 cross-sections of the artery; n represents the total number of multiple cross-sections (that is, the total number of corresponding sampling points 200); D max, i is on the cross-section i , the artery The maximum diameter; D min,i is the minimum diameter of the artery on the section i ; V i is a vasodilation ratio corresponding to the section i; and Vavg represents the average vasodilation ratio of the artery.

2. 平均血管舒張比模型與FFR的相關性2. The correlation between the average vasodilation ratio model and FFR

25位病患平均血管舒張比的的平均統計結果呈現於第2圖,其中,對每個病患而言,平均血管舒張比與FFR值滿足以下的方程式 V avg =-1.13 FFR+1.1954,且相關係數為約-0.92。 The average statistical results of the average vasodilation ratio of 25 patients are shown in Figure 2. For each patient, the average vasodilation ratio and FFR value satisfy the following equation: V avg =-1.13 FFR+1.1954, and The correlation coefficient is about -0.92.

3. 透過實施例1的平均血管舒張比模型來判斷動脈阻塞程度3. Judge the degree of arterial obstruction through the average vasodilation ratio model of Example 1

臨床上,當受試病患的平均血管舒張比小於0.2時,則表示嚴重與急性的動脈阻塞發生機率較小,如此可採用給予該受試病患的其餘臨床病症之較合適的血管擴張劑藥物。相反地,當受試病患的平均血管舒張筆等於或大於0.2時,則考慮給予該受試病患侵入性心臟支架,予以輔助。Clinically, when the average vasodilation ratio of the test patient is less than 0.2, it means that the occurrence of severe and acute arterial obstruction is less likely. Therefore, a more suitable vasodilator for the other clinical conditions of the test patient can be used. drug. Conversely, when the average vasodilator pen of the test patient is equal to or greater than 0.2, the patient is considered to be given an invasive heart stent for assistance.

應當理解的是,前述對實施方式的描述僅是以實施例的方式給出,且本領域所屬技術領域中具有通常知識者可進行各種修改。以上說明書、實施例及實驗結果提供本發明之例示性實施方式之結構與用途的完整描述。雖然上文實施方式中揭露了本發明的各種具體實施例,然其並非用以限定本發明,本發明所屬技術領域中具有通常知識者,在不悖離本發明之原理與精神的情形下,當可對其進行各種更動與修飾,因此本發明之保護範圍當以附隨申請專利範圍所界定者為準。It should be understood that the foregoing description of the embodiments is only given in the form of examples, and various modifications can be made by those with ordinary knowledge in the technical field of the art. The above specification, examples and experimental results provide a complete description of the structure and use of the exemplary embodiments of the present invention. Although various specific embodiments of the present invention are disclosed in the above embodiments, they are not intended to limit the present invention. Those with ordinary knowledge in the technical field to which the present invention belongs, without departing from the principle and spirit of the present invention, Various changes and modifications can be made to it, so the protection scope of the present invention shall be subject to the scope of the accompanying patent application.

100:方法100: method

102、104、106、108:步驟102, 104, 106, 108: steps

為讓本發明的上述與其他目的、特徵、優點與實施例能更明顯易懂,所附圖式之說明如下:In order to make the above and other objects, features, advantages and embodiments of the present invention more comprehensible, the description of the accompanying drawings is as follows:

第1圖是根據本揭示內容實施方式之用以評估動脈阻塞程度之方法100繪示的流程圖;以及FIG. 1 is a flowchart of a method 100 for evaluating the degree of arterial occlusion according to an embodiment of the present disclosure; and

第2圖呈現根據本揭示內容實施例繪示之平均血管舒張比對FFR的回歸線。Figure 2 presents the regression line of the average vasodilation ratio versus FFR drawn according to an embodiment of the present disclosure.

根據慣常的作業方式,圖中各種元件與特徵並未依比例繪製,其繪製方式是為了以最佳的方式呈現本發明相關的具體特徵與元件。此外,在不同的圖式間,以相同或相似的元件符號來指稱相似的元件/部件。According to the usual operation method, the various elements and features in the figure are not drawn to scale, and the drawing method is to present the specific features and elements related to the present invention in the best way. In addition, between different drawings, the same or similar element symbols are used to refer to similar elements/components.

100:方法 100: method

102、104、106、108:步驟 102, 104, 106, 108: steps

Claims (6)

一種用以評估一個體之一動脈阻塞程度的方法,包含:(a)連續拍攝該動脈,以得到該動脈的複數個影像幀;(b)將步驟(a)得到的各該複數個影像幀彼此對齊,以決定該動脈的一邊界以及一中心軸線,其中,藉由在對齊的該複數個影像幀上執行多項式回歸,以決定該動脈的該中心軸線;(c)根據步驟(b)之該中心軸線的法向量,選定該動脈的複數個截面;(d)基於步驟(b)的該邊界,決定該動脈於該複數個影像幀當中,各該複數個截面的一最大直徑及一最小直徑;(e)根據步驟(d)之各該複數個截面的該最大直徑及該最小直徑,計算該動脈的一平均血管舒張比;以及(f)根據步驟(e)之該平均血管舒張比,判斷該動脈的阻塞程度。 A method for evaluating the degree of obstruction of an artery in a body, comprising: (a) continuously photographing the artery to obtain a plurality of image frames of the artery; (b) combining each of the plurality of image frames obtained in step (a) Align with each other to determine a boundary and a central axis of the artery, wherein polynomial regression is performed on the aligned image frames to determine the central axis of the artery; (c) according to step (b) The normal vector of the central axis selects a plurality of cross-sections of the artery; (d) based on the boundary of step (b), determines the artery in the plurality of image frames, a maximum diameter and a minimum of each of the plurality of cross-sections Diameter; (e) calculating an average vasodilation ratio of the artery according to the maximum diameter and the minimum diameter of each of the plurality of cross-sections in step (d); and (f) according to the average vasodilation ratio of step (e) , To determine the degree of blockage of the artery. 如請求項1所述之方法,其中在步驟(e)中,是藉由以下方程式(1)及(2),以計算該平均血管舒張比:V i =(D max,i -D min,i )/D min,i (1),
Figure 109127049-A0305-02-0017-1
其中,i是該動脈之該複數個截面的任一截面;n是該複數個截面的總數;D max,i 是在該截面i上,該動脈的該最大直徑;D min,i 是在該截面i上,該動脈的該最小直徑;V i 是對應該截面i的一血管舒張比;且 V avg 表示該動脈的該平均血管舒張比。
The method according to claim 1, wherein in step (e), the average vasodilation ratio is calculated by the following equations (1) and (2): V i = ( D max,i - D min, i )/ D min,i (1),
Figure 109127049-A0305-02-0017-1
Wherein, i is any cross section of the plurality of cross sections of the artery; n is the total number of the plurality of cross sections; D max,i is on the cross section i , the maximum diameter of the artery; D min,i is on the cross section i, the minimum diameter of the artery; V i should be on a cross-sectional ratio i of vasodilation; and V avg represents the average diastolic blood vessels than the arterial.
如請求項1所述之方法,其中在步驟(a)中,該複數個影像幀是以約每秒30幀至60幀的一幀頻(frame rate)所攝得。 The method according to claim 1, wherein in step (a), the plurality of image frames are captured at a frame rate of about 30 to 60 frames per second. 如請求項1所述之方法,其中在步驟(a)中,該複數個影像幀是在約5秒至8秒的一期間所攝得。 The method according to claim 1, wherein in step (a), the plurality of image frames are captured in a period of about 5 seconds to 8 seconds. 如請求項1所述之方法,其中該方法的特徵在於不包含量測該個體之動脈血流的步驟。 The method according to claim 1, wherein the method is characterized in that it does not include the step of measuring the arterial blood flow of the individual. 如請求項1所述之方法,其中該方法的特徵在於非侵入性地操作,且不使用導管、護套、導引線或其組合的任一種。The method according to claim 1, wherein the method is characterized by being operated non-invasively and without using any one of a catheter, a sheath, a guide wire, or a combination thereof.
TW109127049A 2020-08-10 2020-08-10 Method for estimating degree of arterial occlusion TWI740600B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW109127049A TWI740600B (en) 2020-08-10 2020-08-10 Method for estimating degree of arterial occlusion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW109127049A TWI740600B (en) 2020-08-10 2020-08-10 Method for estimating degree of arterial occlusion

Publications (2)

Publication Number Publication Date
TWI740600B true TWI740600B (en) 2021-09-21
TW202206017A TW202206017A (en) 2022-02-16

Family

ID=78778065

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109127049A TWI740600B (en) 2020-08-10 2020-08-10 Method for estimating degree of arterial occlusion

Country Status (1)

Country Link
TW (1) TWI740600B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005185575A (en) * 2003-12-25 2005-07-14 Gifu Univ System, method and program for arteriosclerosis analysis
CN108836280A (en) * 2012-12-12 2018-11-20 光学实验室成像公司 For automatically determining the method and device of intravascular space profile

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005185575A (en) * 2003-12-25 2005-07-14 Gifu Univ System, method and program for arteriosclerosis analysis
CN108836280A (en) * 2012-12-12 2018-11-20 光学实验室成像公司 For automatically determining the method and device of intravascular space profile

Also Published As

Publication number Publication date
TW202206017A (en) 2022-02-16

Similar Documents

Publication Publication Date Title
CN107730540B (en) Coronary parameter calculation method based on high-precision matching model
US10395774B2 (en) Vascular flow assessment
JP6553099B2 (en) Device for calculating blood flow reserve ratio value
US8977339B1 (en) Method for assessing stenosis severity through stenosis mapping
JP6667999B2 (en) Image processing apparatus, image processing method, and program
JP6685319B2 (en) Method and apparatus for quantitative flow analysis
US20210338088A1 (en) Method and Apparatus for Quantitative Hemodynamic Flow Analysis
JP6386027B2 (en) Stenosis treatment plan
CN109036551B (en) Coronary artery physiological index relation establishing and applying method and device
US11195278B2 (en) Fractional flow reserve simulation parameter customization, calibration and/or training
JP7303260B2 (en) A method for determining flow and pressure gradients in arterial networks from contrast distributions based on patient-specific computed tomography algorithms.
JP6362851B2 (en) Blood vessel analysis device, blood vessel analysis program, and blood vessel analysis device operating method
CN102085100A (en) Medical image processing apparatus and medical image processing method
JP6133794B2 (en) Dynamic normalization of data for perfusion comparison and quantification.
JP6873981B2 (en) Mobile FFR simulation
CN112535466A (en) Blood flow reserve fraction calculation method based on blood vessel image
JP2021104337A (en) Estimating endoluminal path of endoluminal device along lumen
CN109907772A (en) The method and apparatus for obtaining coronary blood flow and blood flow velocity
US20220319004A1 (en) Automatic vessel analysis from 2d images
TWI740600B (en) Method for estimating degree of arterial occlusion
JP6675458B2 (en) Blood vessel analysis device, blood vessel analysis method, and blood vessel analysis program
CN113995388A (en) Fractional flow reserve calculation method and device, electronic equipment and readable storage medium
KR20180077140A (en) Method for determining cardiovascular information using mathematical modeling of stenosed lesion
US11741599B2 (en) Method for treating arterial stenosis
US20240135530A1 (en) Method and apparatus for analyzing blood vessel based on machine learning model